People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akari Therapeutics Plc | — | Biotechnology | Series C | $140.5M | $34.1M | 2023 |
| Quench Usa, Inc. | — | Other | Series B | $46.4M | $282.5M | 2010 |
| Cannapharmarx, Inc. | — | Other | Series B | $38.8M | $2.8M | 2015 |
| ExpressCells, Inc. | — | Biotechnology | Seed | $1.8M | $22.1M | 2020 |
Wendy DiCicco at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wendy DiCicco on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Sidransky | 1 | 7 |
| Samir Patel | 1 | 7 |
| Hoyoung Huh | 1 | 7 |
| James Hill | 1 | 6 |
| Gary Cohen | 1 | 6 |
| Tom Anderson | 1 | 5 |
| MARK COHEN | 1 | 5 |
| Donald Williams | 1 | 4 |
| Douglas Brown | 1 | 4 |
| Yuval Cohen | 1 | 4 |
| Michael Bevan | 1 | 3 |
| DOV ELEFANT | 1 | 3 |
| Johnson Lau | 1 | 3 |
| Todd Peterson | 1 | 3 |
| Matthew Nicosia | 1 | 3 |
| JAMES SMEEDING | 1 | 3 |
| GERRY CROCKER | 1 | 2 |
| Evan Lovell | 1 | 2 |
| GARY HERICK | 1 | 2 |
| Anthony Ibarguen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.